Emcure Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Postal Ballot
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals has informed the stock exchanges that shareholders have approved, via postal ballot, the appointment of Mr. C S Muralidharan (DIN: 00014740) as an Independent Director of the company. Mr. Muralidharan was initially appointed as an Additional Director (Non-Executive and Independent) with effect from April 1, 2026, and his appointment has now been confirmed by shareholders as a special resolution for a 3-year term. The remote e-voting window ran from March 26 to April 24, 2026, and scrutinizer Ms. Ashwini Inamdar confirmed the process was conducted fairly and transparently. The resolution was passed with the requisite majority, though exact voting percentages are not disclosed in this filing.
This is a routine corporate governance update that formalises an existing board appointment and is unlikely to have any material impact on the stock price. It simply ensures regulatory compliance for Mr. Muralidharan's continuation as an Independent Director for the next three years.